低髂股钙化评分或预测EVAR与FEVAR术后更高生存率
本研究评估髂股钙化评分与肾下腹主动脉瘤腔内修复(EVAR)或开窗腔内修复(FEVAR)后长期死亡率的关系。404例患者中,最低四分位钙化评分者5年总生存率和无心脏事件生存率显著更高,但钙化评分与生存的回归分析无显著关联。
要点
- 髂股钙化评分最低四分位者5年总生存率79±4% vs 71±3%(P=0.01)。
- 最低四分位者5年无心脏事件生存率95±2% vs 91±2%(P=0.033)。
- 钙化评分与生存的回归分析无显著关联(OR 1.016,95%CI 0.988-1.045,P=0.268)。
核心结论
- 低髂股钙化评分可能与EVAR和FEVAR术后致命心脏事件及全因长期死亡率较低相关。
- 该关联可能部分反映衰老和心血管合并症,需进一步研究。
研究设计与样本
- 单中心回顾性队列研究,纳入2004至2012年接受EVAR或FEVAR的非破裂腹主动脉瘤患者。
- 651例患者中404例(62.05%)因术前非增强CT图像质量足够被纳入。
- 从主动脉分叉至股总动脉测量Agatston钙化评分,中位随访6.3(4.7-8.4)年。
主要发现
- 髂股钙化评分中位数为8348(3830-14179)。
- 纳入与排除患者生存无差异(P=0.33)。
- 30天内死亡9例(2.2%)。
- 5年估计总生存率为73±2%。
- 最低四分位钙化评分者5年总生存率79±4% vs 其余71±3%(P=0.01),无心脏事件生存率95±2% vs 91±2%(P=0.033)。
临床怎么用
- 术前非增强CT测量的髂股钙化评分可能辅助识别EVAR/FEVAR术后心脏事件和死亡高风险患者。
- 低钙化评分者长期预后较好,但评分本身并非独立预测因子,需结合其他因素综合评估。
局限性
- 单中心回顾性设计。
- 仅62.05%患者图像质量满足钙化评分要求。
- 钙化评分与生存的回归分析未显示独立关联,提示混杂因素影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Abdominal aortic aneurysm is associated with an increased mortality, mostly cardiovascular events. Moreover, aortoiliac calcification is associated with increased mortality in patients with peripheral occlusive disease. The aim of this study is to assess the potential association between iliofemoral calcification, assessed by calcium score, in patients undergoing infrarenal (endovascular aneurysm repair [EVAR]) or fenestrated endovascular aortic repair (FEVAR) and long-term mortality, particularly caused by cardiac events. METHODS: All patients with preoperative noncontrast-enhanced computed tomographic scans who underwent infrarenal EVAR and FEVAR of nonruptured abdominal aortic aneurysm between 2004 and 2012 at a single tertiary center were screened for inclusion. Agatston calcium score was measured from the aortic bifurcation to common femoral arteries using a dedicated postprocessing software. The values are presented as median and interquartile range. RESULTS: About 404 (62.05%) of 651 patients who underwent EVAR and FEVAR had sufficient imaging quality to be included. There was no difference in survival between included and excluded patients (P = 0.33). Nine patients (2.2%) died within 30 days of the operation, whereas the remaining were followed up for 6.3 (4.7-8.4) years. The iliofemoral calcium score was 8348 (3830-14,179). Estimated overall survival at 5 years was 73 ± 2%. Patients within the lowest quartile of iliofemoral calcium score had significantly higher overall survival (5 years: 79 ± 4% vs. 71 ± 3%; P = 0.01) and cardiac event-free survival (5 years: 95 ± 2% vs. 91 ± 2%; P = 0.033) when compared with the remaining ones. Calcium score was associated with neither univariate regression analysis with survival (odds ratio, 1.016 [0.988-1.045]; P = 0.268) nor cardiac event-free survival (odds ratio, 1.024 [0.986-1.063]; P = 0.222). CONCLUSIONS: Low iliofemoral calcium score may be associated with lower incidence of fatal cardiac events and all-cause long-term mortality after EVAR and FEVAR. This may be partially a reflection of aging and cardiovascular comorbidity but needs to be studied further.
引用
- Vaccarino R, Abdulrasak M, Resch T, et al. Low Iliofemoral Calcium Score May Predict Higher Survival after EVAR and FEVAR. Ann Vasc Surg. 2020. PMID: 32339675. doi:10.1016/j.avsg.2020.04.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。